§ JOURNAL · Guide
Multi-Jurisdiction Patent Drafting Workflow: An In-Depth Side-by-Side Analysis of CN, US, EP, JP, KR, and PCT
For IP firms managing global patent portfolios, a single invention spawns six subtly different application documents across jurisdictions — each with its own specification section order, claim format conventions, unique procedural mechanisms, and examiner culture. This is not a translation problem; it is a substantive jurisdiction-adaptation problem.
This article provides a side-by-side operational analysis of the patent drafting workflows across six major jurisdictions — CN (CNIPA), US (USPTO), EP (EPO), JP (JPO), KR (KIPO), and PCT — focusing on the practical differences that help practitioner teams identify the key risk points in cross-jurisdictional practice.
I. Specification Section Structure: The Skeletal Differences Across Six Jurisdictions
The specification section order and heading format are the most immediately visible and quantifiable differences across the six jurisdictions. They are also the fundamental reason why AI tools must maintain six independent specification templates rather than a single translation layer.
| Section Equivalent | CN (CNIPA) | US (37 CFR 1.77) | EP (Rule 42 EPC) | JP (JPO) | KR (KIPO) | PCT (Rule 5) |
|---|---|---|---|---|---|---|
| Invention title | 发明名称 | TITLE OF THE INVENTION | Title of the Invention | 【発明の名称】 | 【발명의 명칭】 | Title |
| Technical field | 技术领域 | (included in BACKGROUND) | Technical Field | 【技術分野】 | 【기술분야】 | Technical Field |
| Background art | 背景技术 | BACKGROUND OF THE INVENTION | Background Art | 【背景技術】 | 【배경기술】 | Background Art |
| Summary | 发明内容 | BRIEF SUMMARY OF THE INVENTION | Disclosure of the Invention | 【発明の概要】 (with sub-sections) | 【발명의 내용】 (with sub-sections) | Disclosure of Invention |
| Drawings description | 附图说明 | BRIEF DESCRIPTION OF THE DRAWINGS | Brief Description of Drawings | 【図面の簡単な説明】 | 【도면의 간단한 설명】 | Brief Description of Drawings |
| Embodiments | 具体实施方式 | DETAILED DESCRIPTION OF THE INVENTION | Detailed Description of Embodiments | 【発明を実施するための形態】 | 【발명을 실시하기 위한 구체적인 내용】 | Best Mode for Carrying Out the Invention |
| Claims | 权利要求书 (standalone) | CLAIMS (new page) | Claims | 特許請求の範囲 | 청구범위 | Claims |
| Abstract | 摘要 (standalone) | ABSTRACT OF THE DISCLOSURE (new page) | Abstract | 要約書 | 요약서 | Abstract |
| Industrial applicability | Implied in summary | Not required | Industrial Applicability (if not obvious) | 【産業上の利用可能性】 (optional) | None | Industrial Applicability (if not obvious) |
Heading Format Differences by Jurisdiction
- US: Section headings must be in ALL CAPS — no bold, no underline, no italics. This is a hard requirement of 37 CFR 1.77, not a stylistic preference.
- JP/KR: Section headings are wrapped in full-width brackets 【】. This is a formality requirement checked by JPO and KIPO during formality examination.
- EP: Standard title-case headings; no special formatting required.
- CN: No mandatory heading format; industry conventions have become widely accepted.
The JP/KR "Summary" Sub-Section Structure
Japan and Korea both split the Chinese "Summary of Invention" section into three mandatory sub-sections, reflecting both countries' patent systems' emphasis on a problem-solution-effect tripartite structure:
Japan:
- 【発明が解決しようとする課題】 — Technical problem the invention addresses
- 【課題を解決するための手段】 — Means for solving the problem
- 【発明の効果】 — Effect of the invention
Korea:
- 【해결하고자 하는 과제】 — Problem to be solved
- 【과제의 해결 수단】 — Means for solving the problem
- 【발명의 효과】 — Effect of the invention
This means that when drafting a JP or KR specification, the technical analysis stage must explicitly produce the problem-means-effect tripartite structure — rather than the relatively open-ended "Summary of Invention" approach common in Chinese practice.
II. Claim Formats and Drafting Conventions
Claim format differences directly affect how the scope of protection is interpreted — these are the highest-complexity differences in a six-jurisdiction workflow.
Independent Claim Format Templates by Jurisdiction
| Jurisdiction | Transitional Language / Marker | Example Structure |
|---|---|---|
| CN | 其特征在于，包括/采用 | 一种{X}，其特征在于，包括：{A}；{B}；{C}。 |
| US | comprising / consisting of | A method for {X}, comprising: {A}; {B}; and {C}. |
| EP | characterised in that | A {preamble based on prior art}, characterised in that {new features}. |
| JP | ことを特徴とする | 〜を備えることを特徴とする{subject}。 |
| KR | 것을 특징으로 하는 | 〜을 포함하는 것을 특징으로 하는 {subject}. |
| PCT | comprising (primarily US-style) | Aligned with US; with space reserved for EP two-part form adaptation |
The EP Two-Part Claim Form: A Distinctive Requirement
The European Patent Office (EPO), under EPC Rule 43(1), recommends the two-part claim form — the most distinctive format difference among the six jurisdictions:
[Preamble: describing all features known from the closest prior art]
characterised in that
[Characterizing portion: describing the new features of the invention over the closest prior art]
Practical implications of the two-part form: before drafting EP claims, the "closest prior art" must be identified. Features in the preamble are treated legally as known features, and the examiner will compare them against the closest prior art to verify accuracy. If features that are not actually part of the prior art are included in the preamble, this may create adverse consequences in subsequent invalidity proceedings.
For EP applications derived directly from CN applications, the Chinese single-part form (its characteristic in that) cannot be directly converted to the EP two-part form — a patent search must be conducted to identify the closest prior art before reconstructing the claim structure.
JP/KR Prohibition on Multi-Multi Dependent Claims
Japan and Korea have, since 2022, prohibited "multiply-dependent claims referencing other multiply-dependent claims" — that is, a claim cannot simultaneously reference multiple claims that are themselves multiply-dependent. The US has a similar restriction.
This rule has a substantive impact on claim structure: when adapting US/EP applications for JP/KR, the claim tree may need to be structurally reorganized rather than simply translated.
Excess Claim Fee Comparison
| Jurisdiction | Excess Fee Trigger |
|---|---|
| US (USPTO) | Total claims exceeding 20, or independent claims exceeding 3 |
| EP (EPO) | Claims exceeding 15; each additional claim charged at €265 (tiered: 16–50 claims) |
| CN (CNIPA) | Claims exceeding 10; each additional claim charged a supplemental fee |
| JP (JPO) | More than 1 independent claim requires justification of unity of invention |
| KR (KIPO) | Claims exceeding 20; each additional claim charged |
III. Unique Procedural Mechanisms by Jurisdiction
Every patent office has procedural tools that exist nowhere else. These mechanisms govern filing strategy — not knowing them means missing critical opportunities or triggering irreversible procedural risks.
US-Unique Mechanisms
Provisional Application: A 12-month priority placeholder document — no claims or oath required, relaxed format, low cost (small entity: $130). Ideal for locking in a priority date before a product is mature, with a non-provisional application filed within 12 months. No equivalent exists in China, Europe, or Japan.
IDS (Information Disclosure Statement): The duty of candor and good faith under 37 CFR 1.56 requires disclosure of all known information material to patentability. Violation can render the entire patent unenforceable (inequitable conduct); under the Therasense standard, both materiality and specific intent to deceive must be proven.
Continuation / CIP / Divisional: The continuation practice allows filing new sets of claims (Continuation) or supplementing new disclosure (CIP) while the parent application is still pending, or splitting claims with insufficient unity (Divisional). This system gives US applicants a tool to continuously strengthen a patent portfolio throughout the life of the parent patent.
Track One Prioritized Examination: By paying an additional fee (large entity: $4,200), the applicant can request prioritized examination — USPTO commits to completing the first Office Action within 6 months.
EP-Unique Mechanisms
Extended European Search Report (EESR): EPO automatically issues a search report before inviting substantive examination; applicants use this to decide whether to continue prosecution.
Post-Grant Opposition: Any third party may oppose an EP patent at EPO within 9 months of grant, requesting revocation. Opposition is resolved internally at EPO without requiring national court proceedings — it is the primary low-cost tool for competitors to challenge EP patents.
National Validation: After an EP patent is granted, the patent holder must complete national validation in each designated contracting state within 3 months, and in some countries (such as France) submit translations into the official language. Validation rights are forfeited if the deadline is missed.
Description Adaptation: EPO requires that portions of the specification contradicting the finally allowed claims be amended before grant, to ensure consistency. This step is frequently overlooked by non-European practitioners but has real implications for the validity of European patents.
JP-Unique Mechanisms
Examination Request Period (3 years): Japanese patent applications must be accompanied by an examination request within 3 years of filing; failure to request is deemed abandonment. This mirrors China's 3-year requirement, but in practice JPO does not proactively remind applicants.
New Matter Restriction (Extremely Strict): JPO's new matter restriction on specification amendments is extremely stringent — content not explicitly described in the specification can almost never be added as new claim language after filing. This requires the initial specification to comprehensively cover all implementation variants, leaving room for future claim amendments.
Mandatory Paragraph Numbering: Japanese specifications must use four-digit paragraph numbers (【0001】, 【0002】...) at the beginning of each paragraph; these numbers carry important legal significance in amendment cross-references. This is a formatting requirement that AI tools must handle automatically.
KR-Unique Mechanisms
Separated Application (분리출원): Korea's 2022 revised separated application procedure allows an application to be filed targeting potentially allowable subject matter within 30 days of a final rejection by the Patent Trial and Appeal Board — a remedy mechanism that does not exist in Japan.
Utility Model (실용신안): Korea retains the utility model system, with a shorter examination cycle (approximately 1 year) and 10-year protection term, suitable for products with short life cycles. The US has no equivalent; China and Japan have similar systems.
PCT-Unique Mechanisms
International Search Phase (ISR/WO): An International Searching Authority (ISA) issues an International Search Report (ISR) and Written Opinion (WO), evaluating the novelty and inventive step of the claims. The ISR is completed before national phase entry, providing applicants with important input for assessing patent value.
International Preliminary Examination (Chapter II): Applicants may optionally request Chapter II international preliminary examination for a more detailed patentability assessment, with the opportunity to amend claims before national phase entry.
30/31-Month National Phase Entry Window: PCT applications must enter the national phase in each country within 30 months (31 months for some countries) of the priority date; missing the deadline forfeits patent rights in that country.
IV. Patent Family Strategy: Route Planning from CN to Global
For Chinese-priority cases, the route planning for a patent family directly affects the quality and cost of the global patent portfolio.
Typical Route: CN → PCT → National Phases
Month 0: File CN invention patent application (establish priority date)
Month 12: File PCT international application (claim CN priority; automatically designates all PCT member states)
Months 12-18: PCT international phase
├── International Search Report (ISR) issued
├── Written Opinion (WO)
└── Optional: Chapter II international preliminary examination
Months 30-31: Enter national phases
├── US: submit English claims + specification
├── EP: submit English application; designate European member states
├── JP: submit English application + Japanese translation within 14 months
└── KR: submit English application + Korean translation within 14 months
Business Logic for Route Selection
Not every invention needs to follow the PCT route. Route selection should be based on the technical field, target markets, and commercial lifecycle of the invention:
| Invention Type | Recommended Route | Rationale |
|---|---|---|
| Software / Internet | CN → US (direct) | Short lifecycle; US and Chinese markets are primary; PCT timeline too slow |
| Semiconductor / Chip | CN → PCT → US/JP/KR | Global supply chain requires multi-jurisdiction protection; PCT search report provides valuable input |
| Medical device / Biotech | CN → PCT → US/EP/JP | Long regulatory approval cycle; high patent lifecycle value; EP/US markets critical |
| Mechanical / Industrial equipment | CN → US/EP (direct) | Target markets clearly defined; PCT can be skipped to save cost |
| Automotive components | CN → PCT → US/EP/JP/KR | Global procurement requires comprehensive coverage |
Key Preparation for PCT National Phase Entry
Before entering each national phase, the PCT claims must be adapted for the target jurisdiction:
- Entering EP: Rewrite PCT single-part claims as EP two-part form; identify the closest prior art
- Entering JP: Restructure specification into the three-sub-section format (problem / means / effect); add mandatory paragraph numbers
- Entering KR: Adjust abstract structure (problem / solution means); check multi-dependent claim format
- Entering US: Confirm claim format (comprising); prepare IDS; complete ADS (declaring PCT priority)
V. Abstract Requirements Compared: Where the Details Trap You
The abstract is the most easily overlooked document yet has some of the most varied requirements across jurisdictions:
| Jurisdiction | Word / Character Limit | Structured Format? | Drawing Requirement |
|---|---|---|---|
| CN | ≤300 Chinese characters | No | Select one drawing best illustrating the invention |
| US | ≤150 words | No | Abstract on separate page; no specific abstract drawing requirement |
| EP | ≤150 words | No | EPO examiner selects the best figure |
| JP | ≤400 Japanese characters | No | Must designate a representative drawing |
| KR | ≤400 Korean characters | Yes — divided into problem and solution means | Must designate a representative drawing |
| PCT | 50–150 words (English) | No | Attach most relevant figure if applicable |
The Korean abstract's structured format requirement is unique among the six jurisdictions: it must be divided into "과제 (problem)" and "해결수단 (solution means)" — not a general technical summary. This requires the KR abstract to be prepared separately rather than translated directly from the CN abstract.
VI. Translation Challenges and Terminology Consistency
In multi-jurisdiction filings, translation is not a simple language conversion — it is a technical translation with legal consequences. Terminology inconsistencies can produce unpredictable results years later in infringement or invalidity proceedings.
Three Core Categories of Translation Risk
Expansion or narrowing of key claim terms: When translating the Chinese "包括" into English, "comprising" (open-ended; additional features permissible) and "consisting of" (closed-ended; no additional features) are fundamentally different in law. Choosing the wrong transitional phrase can transform a broad Chinese claim into an extremely narrow English claim.
Consistency of technical terminology: Using different expressions for the same technical feature in different parts of the specification may trigger a "disclaimer" in the US — USPTO examiners may treat the two different expressions as a deliberate distinction by the applicant, thereby narrowing the claim scope. In Japan, because new matter restrictions are strict, new terms introduced during translation cannot later become part of the claims in amendments.
Legal consequences of JP/KR translation quality: Both Japan and Korea allow initial filing in English with a translation to be submitted later (JP: 14 months; KR: 14 months), but once translation quality issues enter prosecution, amendment restrictions in Korea are particularly strict — terminology inconsistencies in the translated document can directly constrain the scope of available claim amendments.
Practical Recommendations for Terminology Consistency Management
It is recommended to establish a Terminology Glossary in patent family management: for each core invention, build a four-language (Chinese-English-Japanese-Korean) terminology reference table at the time the CN application is filed, and have all subsequent jurisdiction practitioners reference it consistently during translation. The upfront investment in this work can significantly reduce the risk of translation disputes in infringement litigation years later.
VII. Implications for Law Firm Team Organization
Parallel prosecution across six jurisdictions is not simply a multiplication of workload — it is a systemic challenge to the firm's organizational model.
Specialization Model
For larger firms handling multi-jurisdiction work, it is recommended to organize specialized groups by jurisdiction:
| Function | Recommended Configuration |
|---|---|
| CN priority drafting | Chinese patent agent; responsible for original invention mining and initial draft |
| US adaptation | USPTO-registered patent agent; responsible for claim restructuring and IDS management |
| EP adaptation | European Patent Attorney (EPA); responsible for two-part form restructuring and Description Adaptation |
| JP/KR adaptation | Japanese benrishi / Korean byeonrisa; responsible for language translation and format conversion |
| PCT strategy | Senior multi-jurisdiction practitioner; responsible for national phase entry strategy and timeline management |
Key Coordination Nodes in the Workflow
Node 1 — When CN application is filed: Simultaneously initiate multi-jurisdiction strategy discussion; determine whether to pursue PCT; confirm target countries; begin building the terminology glossary.
Node 2 — When CN application is published: Assess prioritization of patent family filings; adjust strategy.
Node 3 — After PCT filing (when ISR is issued): Based on the search report, assess grant prospects; decide which countries merit national phase entry.
Node 4 — 3 months before the 30/31-month national phase deadline: Launch claim adaptation work for each jurisdiction; prepare translation documents.
Positioning AI Tools in the Multi-Jurisdiction Workflow
The core value of AI patent drafting tools designed for multi-jurisdiction use lies in:
- Maintaining six independent specification templates — not a single template with a translation layer
- Automatically recognizing the format requirements of the current jurisdiction (section order, heading format, word/character limits)
- Automatically switching claim format templates by jurisdiction when generating claims (single-part / two-part / JP format / KR format)
- Terminology consistency checking — flagging inconsistencies within the same document
- Automatic JP paragraph number generation (【0001】 format)
- Multi-jurisdiction deadline management (reminders for 30/31-month national phase entry)
It should be noted that key judgments that AI tools currently cannot handle include: selection of the "closest prior art" for EP two-part claims, materiality determinations for IDS references, and amendment strategies in each jurisdiction. These remain the irreplaceable professional core of human patent practitioners.
The central challenge of cross-jurisdiction patent drafting lies not in the increased volume of documents, but in the fact that every jurisdiction has its own internal legal logic and practice conventions. The EP two-part form builds scope of protection within a closest-prior-art framework; the JP three-sub-section structure reflects a problem-oriented drafting philosophy; the US IDS embodies a culture of candor obligations. Truly mastering multi-jurisdiction practice requires understanding the legislative rationale behind each system — not merely copying format templates. For firms building multi-jurisdiction service capabilities, the recommended approach is to start with CN-priority cases, progressively refine the US and EP adaptation workflows, then expand to JP/KR, and ultimately develop full-cycle PCT international application management capability.
❖ INVITATION
Get Started with CNIPA.AI
Sign up now and experience AI-powered patent search and writing
Sign Up Free